Patents by Inventor Marco Idzko

Marco Idzko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of PDE4 Inhibitors for the Prophylaxis and/or Therapy of Dyslipoproteinaemia and Related Disorders
    Publication number: 20180318271
    Abstract: The present invention discloses new medical uses of phosphodiesterase 4 (PDE 4) inhibitors for treating dyslipoproteinaemia and of diseases when respectively correlated or associated with dyslipoproteinaemia or lipoprotein imbalance, in particular abnormally high low density lipoprotein (LDL) in blood or serum, such as endothelial dysfunction, cardiovascular diseases, in particular arteriosclerosis, myocardial infarction, stroke, peripheral artery disease, and vascular stenosis or restenosis, independent and distinct from inflammatory diseases or conditions such as inflammatory-associated cardiovascular pathology and cardiac hypertrophy. Accordingly the present invention allows reducing cardiovascular risks in new clinical settings, especially in circumstances of abnormal high LDL levels and especially LDL-cholesterol and LDL-triglyceride levels.
    Type: Application
    Filed: November 4, 2016
    Publication date: November 8, 2018
    Applicant: Albert-Ludwigs-Universität Freiburg
    Inventors: Christoph Ahlgrim, Manfred Baumstark, Marco Idzko
  • Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis
    Patent number: 9795625
    Abstract: The present invention relates to the new indications of chronic obstructive pulmonary disease (COPD) and idiophathic lung fibrosis (IPF) for uridine and uridine analogs.
    Type: Grant
    Filed: April 12, 2016
    Date of Patent: October 24, 2017
    Assignee: Universitaetsklinikum Freiburg
    Inventors: Marco Idzko, Stephan Sorichter
  • URIDINE AND URIDINE ANALOGUES FOR TREATMENT OF SPECIFIC LUNG DISEASES, NAMELY COPD AND PULMONARY FIBROSIS
    Publication number: 20160220597
    Abstract: The present invention relates to the new indications of chronic obstructive pulmonary disease (COPD) and idiophathic lung fibrosis (IPF) for uridine and uridine analogues.
    Type: Application
    Filed: April 12, 2016
    Publication date: August 4, 2016
    Applicant: Universitaetsklinikum Freiburg
    Inventors: Marco IDZKO, Stephan SORICHTER
  • Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis
    Patent number: 9333216
    Abstract: The present invention relates to the new indications of chronic obstructive pulmonary disease (COPD) and idiophathic lung fibrosis (IPF) for uridine and uridine analogues.
    Type: Grant
    Filed: July 24, 2012
    Date of Patent: May 10, 2016
    Assignee: Universitaetsklinikum Freiburg
    Inventors: Marco Idzko, Stephan Sorichter
  • URIDINE AND URIDINE ANALOGUES FOR TREATMENT OF SPECIFIC LUNG DISEASES, NAMELY COPD AND PULMONARY FIBROSIS
    Publication number: 20140323427
    Abstract: The present invention relates to the new indications of chronic obstructive pulmonary disease (COPD) and idiophathic lung fibrosis (IPF) for uridine and uridine analogues.
    Type: Application
    Filed: July 24, 2012
    Publication date: October 30, 2014
    Applicant: Universitaetsklinikum Freiburg
    Inventors: Marco Idzko, Stephan Sorichter